ANI Pharmaceuticals Ownership | Who Owns ANI Pharmaceuticals?

Overview Forecast RevenueFinancials Chart Transcripts

ANI Pharmaceuticals Ownership Summary

ANI Pharmaceuticals is owned by 96.52% institutional investors, 10.66% insiders. Blackrock is the largest institutional shareholder, holding 13.91% of ANIP shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 4.68% of its assets in ANI Pharmaceuticals shares.

ANIP Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	ANI Pharmaceuticals	96.52%	10.66%	-7.18%
Sector	Healthcare Stocks	488.17%	11.08%	-399.26%
Industry	Specialty & Generic Drug Manufacturers Stocks	43.51%	11.55%	44.95%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock	2.66M	13.91%	$169.17M
Blackrock funding, inc. /de	2.58M	13.01%	$168.38M
Vanguard group	1.31M	6.77%	$72.66M
Millennium management	1.00M	5.17%	$55.44M
Global alpha capital management	862.09K	4.35%	$56.25M
State street	737.29K	3.80%	$40.76M
Goldman sachs group	699.62K	3.61%	$38.67M
Dimensional fund advisors lp	685.73K	3.53%	$37.91M
Deep track capital, lp	700.00K	3.53%	$45.67M
Ubs group	594.81K	3.07%	$32.88M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Global alpha capital management	862.09K	3.51%	$56.25M
Apis capital advisors	128.00K	2.97%	$8.35M
Sio capital management	112.92K	2.81%	$7.37M
Stonepine capital management	38.60K	2.47%	$2.52M
Ranger investment management	577.74K	2.02%	$31.94M
Lisanti capital growth	95.17K	1.72%	$6.21M
Deep track capital, lp	700.00K	1.46%	$45.67M
Marathon capital management	72.03K	1.20%	$4.70M
Tang capital management	317.50K	1.05%	$20.72M
Parkman healthcare partners	128.48K	0.96%	$8.38M

Top Buyers

Holder	Shares	% Assets	Change
Millennium management	1.00M	0.03%	473.10K
Ubs group	594.81K	0.01%	308.32K
Freestone grove partners lp	195.21K	0.10%	191.22K
Global alpha capital management	862.09K	3.51%	126.50K
Blackrock	2.66M	0.00%	125.17K

Top Sellers

Holder	Shares	% Assets	Change
Jpmorgan chase	268.05K	0.00%	-286.79K
Soleus capital management	50.74K	0.22%	-173.94K
Woodline partners lp	-	-	-166.45K
Nuveen asset management	49.64K	0.00%	-132.38K
Assenagon asset management	12.89K	0.00%	-101.73K

New Positions

Holder	Shares	% Assets	Change	Value
Pdt partners	45.44K	0.17%	45.44K	$2.97M
Amundi	23.63K	0.00%	23.63K	$1.54M
Phoenix	15.00K	0.00%	15.00K	$10.61K
Quantedge capital pte	11.90K	0.71%	11.90K	$776.48K
Petrus trust company, lta	7.65K	0.05%	7.65K	$499.29K

Sold Out

Holder	Change
Mendota financial group	-1.00
Nelson, van denburg & campbell wealth management group	-1.00
Financial gravity asset management	-1.00
Harbour investments	-1.00
Stephens consulting	-5.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	224	-2.18%	19,142,922	-4.15%	96	0.93%	114	5.56%	70	-4.11%
Mar 31, 2025	229	11.16%	19,974,424	3.61%	101	1.03%	110	11.11%	72	20.00%
Dec 31, 2024	203	-3.33%	19,272,026	1.94%	99	1.05%	98	-21.60%	59	37.21%
Sep 30, 2024	209	1.95%	18,894,593	24.90%	97	1.55%	125	16.82%	43	-30.65%
Jun 30, 2024	203	-1.46%	15,126,958	7.17%	79	1.45%	105	-2.78%	62	19.23%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
iShares Core S&P Small-Cap ETF	1.02M	4.68%	166.00
Vanguard US Total Market Shares ETF	588.25K	2.73%	-
Vanguard Total Stock Mkt Idx Inv	587.04K	2.70%	-13.01K
Pacer US Small Cap Cash Cows 100 ETF	549.63K	2.62%	-1.87K
iShares Russell 2000 ETF	424.65K	1.96%	-8.09K
CC&L Global Alpha - Series A	375.10K	1.73%	-7.20K
Ranger Small Cap	359.19K	1.66%	-19.61K
Delaware Ivy Small Cap Growth C	336.40K	1.60%	-
AZ InvestEd Ivy Small Cap Growth E	264.83K	1.22%	-
Macquarie Small Cap Growth C	264.83K	1.22%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Sep 19, 2025	Davis Krista	SVP, CHIEF HR OFFICER	Sell	$98.04K
Sep 12, 2025	Cook Meredith	SR. VP, GENERAL COUNSEL & SEC.	Sell	$39.37K
Sep 03, 2025	Pera Antonio R	-	Sell	$692.30K
Aug 25, 2025	Leonard Matthew J	-	Sell	$229.09K
Aug 22, 2025	Davis Krista	SVP, CHIEF HR OFFICER	Sell	$160.61K

Insider Transactions Trends

Date	Buy	Sell
2025 Q3	-	20
2025 Q2	-	6
2025 Q1	-	8
2024 Q4	-	8
2024 Q3	-	8

ANIP Ownership FAQ

Who Owns ANI Pharmaceuticals?

ANI Pharmaceuticals shareholders are primarily institutional investors at 96.52%, followed by 10.66% insiders and -7.18% retail investors. The average institutional ownership in ANI Pharmaceuticals's industry, Specialty & Generic Drug Manufacturers Stocks, is 43.51%, which ANI Pharmaceuticals exceeds.

Who owns the most shares of ANI Pharmaceuticals?

ANI Pharmaceuticals’s largest shareholders are Blackrock (2.66M shares, 13.91%), Blackrock funding, inc. /de (2.58M shares, 13.01%), and Vanguard group (1.31M shares, 6.77%). Together, they hold 33.69% of ANI Pharmaceuticals’s total shares outstanding.

Does Blackrock own ANI Pharmaceuticals?

Yes, BlackRock owns 13.91% of ANI Pharmaceuticals, totaling 2.66M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 169.17M$. In the last quarter, BlackRock increased its holdings by 125.17K shares, a 4.94% change.

Who is ANI Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Global alpha capital management is ANI Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 3.51% of its assets in 862.09K ANI Pharmaceuticals shares, valued at 56.25M$.

Who is the top mutual fund holder of ANI Pharmaceuticals shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of ANI Pharmaceuticals shares, with 4.68% of its total shares outstanding invested in 1.02M ANI Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools